Abstract:Axonal degeneration is a common pathological feature in many acute and chronic neurological diseases such as spinal cord injury (SCI). SARM1 (sterile alpha and TIR motif-containing 1), the fifth TLR (Toll-like receptor) adaptor, has diverse functions in the immune and nervous systems, and recently has been identified as a key mediator of Wallerian degeneration (WD). However, the detailed functions of SARM1 after SCI still remain unclear.Methods: Modified Allen's method was used to establish a contusion model of SCI in mice. Furthermore, to address the function of SARM1 after SCI, conditional knockout (CKO) mice in the central nervous system (CNS), SARM1Nestin-CKO mice, and SARM1GFAP-CKO mice were successfully generated by Nestin-Cre and GFAP-Cre transgenic mice crossed with SARM1flox/flox mice, respectively. Immunostaining, Hematoxylin-Eosin (HE) staining, Nissl staining and behavioral test assays such as footprint and Basso Mouse Scale (BMS) scoring were used to examine the roles of SARM1 pathway in SCI based on these conditional knockout mice. Drugs such as FK866, an inhibitor of SARM1, and apoptozole, an inhibitor of heat shock protein 70 (HSP70), were used to further explore the molecular mechanism of SARM1 in neural regeneration after SCI.Results: We found that SARM1 was upregulated in neurons and astrocytes at early stage after SCI. SARM1Nestin-CKO and SARM1GFAP-CKO mice displayed normal development of the spinal cords and motor function. Interestingly, conditional deletion of SARM1 in neurons and astrocytes promoted the functional recovery of behavior performance after SCI. Mechanistically, conditional deletion of SARM1 in neurons and astrocytes promoted neuronal regeneration at intermediate phase after SCI, and reduced neuroinflammation at SCI early phase through downregulation of NF-κB signaling after SCI, which may be due to upregulation of HSP70. Finally, FK866, an inhibitor of SARM1, reduced the neuroinflammation and promoted the neuronal regeneration after SCI.Conclusion: Our results indicate that SARM1-mediated prodegenerative pathway and neuroinflammation promotes the pathological progress of SCI and anti-SARM1 therapeutics are viable and promising approaches for preserving neuronal function after SCI.

Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.

Abstract 73: Wallerian Axon Degeneration is Required for Chronic Neuroinflammation and Infarct-Induced Neurodegeneration

Loss of SARM1 ameliorates secondary thalamic neurodegeneration after cerebral infarction

Sarm1 knockout modifies biomarkers of neurodegeneration and spinal cord circuitry but not disease progression in the mSOD1G93A mouse model of ALS

Sarm1-Dependent Metabolic Reprogramming of Schwann Cells Following Nerve Injury

SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling

Carnosic Acid Improves Outcome after Repetitive Mild Traumatic Brain Injury

Inhibition of Cathepsin S Produces Neuroprotective Effects after Traumatic Brain Injury in Mice

Armcx1 reduces neurological damage via a mitochondrial transport pathway involving Miro1 after traumatic brain injury

SARM1 Activation Promotes Axonal Degeneration Via a Two-Step Liquid-to-Solid Phase Transition

Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1

Traumatic axonal injury in the optic nerve: the selective role of SARM1 in the evolution of distal axonopathy

Armcx1 Attenuates Secondary Brain Injury in an Experimental Traumatic Brain Injury Model in Male Mice by Alleviating Mitochondrial Dysfunction and Neuronal Cell Death.

Sirt1 Attenuates Astrocyte Activation Via Modulating Dnajb1 and Chaperone-Mediated Autophagy After Closed Head Injury

Role of Akt and Mammalian Target of Rapamycin in Functional Outcome after Concussive Brain Injury in Mice

SARM1 Participates in Axonal Degeneration and Mitochondrial Dysfunction in Prion Disease

SARM1 is responsible for calpain-dependent dendrite degeneration in mouse hippocampal neurons

Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma

Phosphorylation at S548 as a Functional Switch of Sterile Alpha and TIR Motif-Containing 1 in Cerebral Ischemia/Reperfusion Injury in Rats

Sarm1/Myd88-5 Regulates Neuronal Intrinsic Immune Response to Traumatic Axonal Injuries.

Gap Junction Intercellular Communications Regulates Activation of SARM1 and Protects Against Axonal Degeneration